Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. April 2019 09:30 ET | Quelle: AngioSoma, Inc.

Diabetes Relief's Programs Can Reduce Costs to Insurance Payers

HOUSTON, TEXAS, April 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma, Inc. (OTC: SOAN) is concerned that economic costs of diabetes in the USA were $327 BILLION in 2017, as reported by...
01. April 2019 09:30 ET | Quelle: AngioSoma, Inc.

AngioSoma Announces New Facility in San Antonio for Diabetes Relief

HOUSTON, TX, April 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma, Inc. (OTC: SOAN) announces that Diabetes Relief LLC has licensed a new facility in San Antonio, Texas for its patented...
14. Dezember 2018 10:57 ET | Quelle: AngioSoma, Inc.

AngioSoma Announces Acquisition of Diabetes Relief

Houston, TX, Dec. 14, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) announced today the Company has entered into a partially binding letter of intent to acquire 100% of...
15. Oktober 2018 06:00 ET | Quelle: AngioSoma, Inc.

New Formula of StemStrength by AngioSoma Inc. Now Available to The Public Online

HOUSTON, TX, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma (OTC: SOAN), a leading biotechnology company, announces today the availability of the anticipated new and improved version...